Lysophosphatidic acid (LPA) is a bioactive lysophospholipid that signals through G protein-coupled receptors (GPCRs) to produce a range of biological responses. A recently reported fourth receptor, LPA 4 /GPR23, was notable for its low homology to the previously identified receptors LPA 1-3 and for its ability to increase intracellular concentrations of cAMP and calcium. However, the signaling pathways leading to LPA 4 -mediated induction of cAMP and calcium levels have not been reported. Using epitope-tagged LPA 4 , pharmacological intervention, and G protein mini-genes, we provide independent confirmatory evidence that supports LPA 4 as a fourth LPA receptor, including LPA concentration-dependent responses and specific membrane binding. Importantly, we further demonstrate new LPAdependent activities of LPA 4 that include the following: receptor internalization; G 12/13 -and Rho-mediated neurite retraction and stress fiber formation; G q protein and pertussis toxin-sensitive calcium mobilization and activation of a nonselective cation conductance; and cAMP increases mediated by G s . The receptor is broadly expressed in embryonic tissues, including brain, as determined by Northern blot and reverse transcription-PCR analysis. Adult tissues have increased expression in skin, heart, and to a lesser extent, thymus. These data confirm the identification and extend the functionality of LPA 4 as an LPA receptor, bringing the number of independently verified LPA receptors to five, with both overlapping and distinct signaling properties and tissue expression.Lysophosphatidic acid (LPA, 2 1-acyl-2-sn-glycerol-3-phosphate) is a water-soluble bioactive phospholipid that can be generated by many cell types and has been shown to influence multiple intracellular signaling pathways, including stimulation of phospholipase C and D, activation of small GTPases, MAPK (mitogen-activated protein kinase), and phosphoinositide 3-kinase (1, 2), and inhibition of adenylyl cyclase (3, 4). LPA signaling through G proteins mediates a variety of biological functions, including cell proliferation, cell survival, cytoskeletal remodeling, cell migration, and alterations in differentiation (3, 5-9). In mice, gene deletion studies of the LPA receptors (10, 11) have shown that LPA receptor-mediated signaling contributes to many other functions in normal and pathological states (12), including vascular and nervous system development (10, 13, 14), female fertility and implantation (15), and the initiation of neuropathic pain (16).Five LPA-specific GPCRs have thus far been identified, termed LPA 1-5 (17-22). LPA 4 is the only receptor that has yet to receive independent confirmation as a bona fide LPA receptor since its initial report (20). This putative LPA receptor was remarkable for its relatively low predicted amino acid sequence homology compared with the well studied LPA 1-3 , a K d Ïł45 nM for LPA, and an ability to mobilize calcium and increase cAMP production (20). Here we confirm the finding that GPR23 is indeed a biologically relevant rece...